About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(tetO-Grin1/GFP)1Jzt
transgene insertion 1, Joe Z Tsien
MGI:3038374
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Grin1tm2Stl/Grin1tm2Stl
Tg(Actb-tTA)1Jzt/0
Tg(Camk2a-cre)62Jzt/0
Tg(tetO-Grin1/GFP)1Jzt/0
involves: 129S4/SvJae * C57BL/6 * CBA MGI:3847227
cn2
Grin1tm2Stl/Grin1tm2Stl
Tg(Actb-tTA)1Jzt/0
Tg(Camk2a-cre)T29-1Stl/0
Tg(tetO-Grin1/GFP)1Jzt/0
involves: C57BL/6 * CBA MGI:3038603


Genotype
MGI:3847227
cn1
Allelic
Composition
Grin1tm2Stl/Grin1tm2Stl
Tg(Actb-tTA)1Jzt/0
Tg(Camk2a-cre)62Jzt/0
Tg(tetO-Grin1/GFP)1Jzt/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grin1tm2Stl mutation (1 available); any Grin1 mutation (66 available)
Tg(Actb-tTA)1Jzt mutation (0 available)
Tg(Camk2a-cre)62Jzt mutation (0 available)
Tg(tetO-Grin1/GFP)1Jzt mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• consolidation and storage of long-term nondeclarative taste memories is impaired in these mice when given doxycycline prior to or within three weeks of training
• mice given doxycycline have impairment of conditioned taste aversion
• mice are trained to avoid saccharin-containing water by being given a LiCl injection after water consumption
• control mice choose unsweetened water about 83.58% of the time 30 days after training
• mutant mice given doxycycline prior to training only choose unsweetened water 32.24% of the time
• mutant mice given doxycycline 2 weeks after training choose unsweetened water 25.63% of the time
• mutant mice given doxycycline 3 weeks to 4 weeks after training choose unsweetened water 27.99% of the time
• mutant mice given doxycycline 4 weeks after training choose unsweetened water at the same frequency as controls




Genotype
MGI:3038603
cn2
Allelic
Composition
Grin1tm2Stl/Grin1tm2Stl
Tg(Actb-tTA)1Jzt/0
Tg(Camk2a-cre)T29-1Stl/0
Tg(tetO-Grin1/GFP)1Jzt/0
Genetic
Background
involves: C57BL/6 * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Grin1tm2Stl mutation (1 available); any Grin1 mutation (66 available)
Tg(Actb-tTA)1Jzt mutation (0 available)
Tg(Camk2a-cre)T29-1Stl mutation (2 available)
Tg(tetO-Grin1/GFP)1Jzt mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• deficits in learning, memory and conditioning are seen in doxycycline treated mutants where expression of Grin1 is knocked out and expression of Grin1-GFP in the CA1 region of the hippocampus is blocked but deficits in learning, memory and conditioning are not seen in untreated mutants
• with doxycycline treatment prior to or immediately after training mutants show significantly fewer freezing responses compared to untreated mutants in a retention test following a fear-conditioning task (J:77659)
• with doxycycline treatment just prior to testing (investigating the role of Grin1 in memory retrieval) no significant difference in a 1-month retention test following a fear-conditioning task is seen (J:77659)
• no difference in cued-fear conditioning behavior is seen with doxycycline treatment (J:77659)
• with doxycycline treatment for 30 days in the seventh month after training mutants show severe deficits in retention of remote contextual fear memory in a 9-month contextual retention test (J:88689)
• no deficit was seen with doxycycline treatment for 7 days in the seventh month after training (J:88689)
• no difference in cued-fear conditioning behavior is seen with doxycycline treatment (J:88689)
• 2 months after stopping doxycycline treatment mutants perform normally in 1-day contextual fear retention, visual memory, open field behavior and rotorod tests (J:88689)
• with doxycycline treatment prior to or immediately after training mutants exhibited longer escape latency in a hidden-platform water maze compared to untreated mutants
• with doxycycline treatment just prior to testing (investigating the role of Grin1 in memory retrieval) no significant difference in escape latency is seen
• deficits in spatial learning and memory are also seen in mutants with doxycycline treatment prior to testing in the transfer test compared to untreated mutants

nervous system
• with doxycycline treatment excitation postsynaptic potentials are absent in the CA1 hippocampal region (J:77659)
• no long-term potentiation is observed in doxycycline treated homozygotes (J:77659)
• with a 5 day doxycycline treatment no long-term potentiation is observed in mutants (J:88689)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory